121 related articles for article (PubMed ID: 33493533)
21. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
[TBL] [Abstract][Full Text] [Related]
22. Suppressors of cytokine signaling promote Fas-induced apoptosis through downregulation of NF-κB and mitochondrial Bfl-1 in leukemic T cells.
Oh J; Kim SH; Ahn S; Lee CE
J Immunol; 2012 Dec; 189(12):5561-71. PubMed ID: 23152563
[TBL] [Abstract][Full Text] [Related]
23. The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway.
Wang D; Li Z; Messing EM; Wu G
J Biol Chem; 2005 Apr; 280(16):16393-401. PubMed ID: 15713673
[TBL] [Abstract][Full Text] [Related]
24. SOCS1 suppresses IL-1β-induced C/EBPβ expression via transcriptional regulation in human chondrocytes.
Ha YJ; Choi YS; Kang EH; Shin K; Kim TK; Song YW; Lee YJ
Exp Mol Med; 2016 Jun; 48(6):e241. PubMed ID: 27339399
[TBL] [Abstract][Full Text] [Related]
25. Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling.
Bayle J; Letard S; Frank R; Dubreuil P; De Sepulveda P
J Biol Chem; 2004 Mar; 279(13):12249-59. PubMed ID: 14707129
[TBL] [Abstract][Full Text] [Related]
26. Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
Organ SL; Tong J; Taylor P; St-Germain JR; Navab R; Moran MF; Tsao MS
J Proteome Res; 2011 Jul; 10(7):3200-11. PubMed ID: 21609022
[TBL] [Abstract][Full Text] [Related]
27. Targeting Lyn tyrosine kinase through protein fusions encompassing motifs of Cbp (Csk-binding protein) and the SOCS box of SOCS1.
Whiting RJ; Payne CJ; Satiaputra J; Kucera N; Qiu TW; Irtegun S; Gunn NJ; Slavova-Azmanova NS; Mulhern TD; Ingley E
Biochem J; 2012 Mar; 442(3):611-20. PubMed ID: 22364282
[TBL] [Abstract][Full Text] [Related]
28. Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.
Maruoka M; Kedashiro S; Ueda Y; Mizutani K; Takai Y
J Biol Chem; 2017 Apr; 292(17):6895-6909. PubMed ID: 28258213
[TBL] [Abstract][Full Text] [Related]
29. The UbL protein UBTD1 stably interacts with the UBE2D family of E2 ubiquitin conjugating enzymes.
Uhler JP; Spåhr H; Farge G; Clavel S; Larsson NG; Falkenberg M; Samuelsson T; Gustafsson CM
Biochem Biophys Res Commun; 2014 Jan; 443(1):7-12. PubMed ID: 24211586
[TBL] [Abstract][Full Text] [Related]
30. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts.
Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R
J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216
[TBL] [Abstract][Full Text] [Related]
31. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
[TBL] [Abstract][Full Text] [Related]
32. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.
Herynk MH; Zhang J; Parikh NU; Gallick GE
J Exp Ther Oncol; 2007; 6(3):205-17. PubMed ID: 17552361
[TBL] [Abstract][Full Text] [Related]
33. The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma.
Shukla A; Khan MGM; Cayarga AA; Namvarpour M; Chowdhury MMH; Levesque D; Lucier JF; Boisvert FM; Ramanathan S; Ilangumaran S
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254783
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine 729 of the G-CSF receptor controls the duration of receptor signaling: involvement of SOCS3 and SOCS1.
Zhuang D; Qiu Y; Haque SJ; Dong F
J Leukoc Biol; 2005 Oct; 78(4):1008-15. PubMed ID: 16033816
[TBL] [Abstract][Full Text] [Related]
35. SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression.
Berzaghi R; Maia VS; Pereira FV; Melo FM; Guedes MS; Origassa CS; Scutti JB; Matsuo AL; Câmara NO; Rodrigues EG; Travassos LR
Sci Rep; 2017 Jan; 7():40585. PubMed ID: 28079159
[TBL] [Abstract][Full Text] [Related]
36. Impaired IFN-gamma-dependent inflammatory responses in human keratinocytes overexpressing the suppressor of cytokine signaling 1.
Federici M; Giustizieri ML; Scarponi C; Girolomoni G; Albanesi C
J Immunol; 2002 Jul; 169(1):434-42. PubMed ID: 12077274
[TBL] [Abstract][Full Text] [Related]
37. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
38. Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis.
Mafanda EK; Kandhi R; Bobbala D; Khan MGM; Nandi M; Menendez A; Ramanathan S; Ilangumaran S
Cytokine; 2019 Dec; 124():154501. PubMed ID: 30097285
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1.
Kandhi R; Bobbala D; Yeganeh M; Mayhue M; Menendez A; Ilangumaran S
Cytokine; 2016 Jun; 82():58-69. PubMed ID: 26748724
[TBL] [Abstract][Full Text] [Related]
40. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met.
Petrelli A; Gilestro GF; Lanzardo S; Comoglio PM; Migone N; Giordano S
Nature; 2002 Mar; 416(6877):187-90. PubMed ID: 11894096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
